Lv2
168 积分 2024-10-11 加入
Endoscopic visual cues of intrarenal pressure during ureteroscopy: in vivo porcine studies
9天前
已完结
Advances in fragment removal devices in ureteroscopy: up-to-date review
9天前
已完结
RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a multi-center phase Ib/II study (HOPE-03)
1个月前
已完结
Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the phase II RC48-C017 trial
1个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
1个月前
已完结
A New Standard in Muscle-Invasive Bladder Cancer — The End of the Cisplatin Era?
1个月前
已完结
A Multimodal Deep Learning Nomogram for the Identification of Clinically Significant Prostate Cancer in Patients with Gray-Zone PSA Levels: Comparison with Clinical and Radiomics Models
3个月前
已完结
Prevention of urinary stones with hydration: a randomised clinical trial of an adherence intervention
4个月前
已完结
The efficacy of continuing aspirin in the perioperative period during percutaneous nephrolithotomy: A systematic review and meta-analysis
5个月前
已关闭
Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU
5个月前
已完结
皖公网安备34019202002308
